Track the 인트론바이오 share price and the full management transaction log of the company, a listed issuer based in South Korea. Shares trade on KR KR, under the supervision of DART (FSS). Operating in the Health Care sector, 인트론바이오 has published 37 reports. Market capitalisation: €79.5bn. The latest transaction was reported on 3 July 2026 (Purchase). Among the most active insiders: 윤성준. Every trade is free.
37
Insider Decl.
n/a
Thresholds
n/a
15 ops.
Buy Volume
n/a
6 ops.
Sell Volume
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 22,448 of 27,989 companies
30.5
score / 100
Value
16
Quality
45
FCF yld-9.7%
Earn yld-11%
EV/EBITDA·
ROE-12%
Gross mgn54%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
인트론바이오 is a company specializing in the health and pharmaceutical sector, listed on the XKRX market. It focuses on developing innovative biopharmaceutical solutions.